1. DSpace at Riga Stradiņš University
  2. Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure
  3. Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure
Please use this identifier to cite or link to this item: 10.2478/prolas-2021-0025
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHartmane, Ilona-
dc.contributor.authorIvdra, Iveta-
dc.contributor.authorMikažāns, Ingmārs-
dc.contributor.authorBondare-Ansberga, Vanda-
dc.date.accessioned2021-11-23T12:40:01Z-
dc.date.available2021-11-23T12:40:01Z-
dc.date.issued2021-06-01-
dc.identifier.citationHartmane , I , Ivdra , I , Mikažāns , I & Bondare-Ansberga , V 2021 , ' Immunopathogenic treatment options for psoriasis patients under a restrictive reimbursement environment ' , Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. , vol. 75 , no. 3 , pp. 158-166 . https://doi.org/10.2478/prolas-2021-0025-
dc.identifier.issn2255-890X-
dc.identifier.otherMendeley: 9d96a89e-a0e5-35fd-a7f9-dfb363df543f-
dc.identifier.otherunpaywall: 10.2478/prolas-2021-0025-
dc.identifier.urihttps://dspace.rsu.lv/jspui/handle/123456789/6870-
dc.descriptionPublisher Copyright: © 2020 Ilona Hartmane et al., published by Sciendo.-
dc.description.abstractThis article is aimed to provide an overview of psoriasis clinical aspects, available treatment options for moderate-to-severe psoriasis in Baltics and summarises recommendations of authors for use of different biologicals in psoriasis patients under a limited reimbursement environment.en
dc.format.extent9-
dc.format.extent597419-
dc.language.isoeng-
dc.relation.ispartofProceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.-
dc.rightsinfo:eu-repo/semantics/openAccess-
dc.subjectautoimmune skin disorder-
dc.subjectbiological therapy-
dc.subjectstate compensation-
dc.subjectBaltic-
dc.subject3.2 Clinical medicine-
dc.subject1.1. Scientific article indexed in Web of Science and/or Scopus database-
dc.titleImmunopathogenic treatment options for psoriasis patients under a restrictive reimbursement environmenten
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/systematicreview-
dc.identifier.doi10.2478/prolas-2021-0025-
dc.contributor.institutionDepartment of Dermatology and Venereology-
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85120936578&partnerID=8YFLogxK-
dc.description.statusPeer reviewed-
Appears in Collections:Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure

Files in This Item:
File SizeFormat 
Immunopathogenic_treatment_options_for_psoriasis_patients.pdf583.42 kBAdobe PDFView/Openopen_acces_unlocked
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.